Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statement of Changes in Stockholders' Equity

v3.26.1
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 51 $ 597,982 $ (3,046) $ (334,030) $ 260,957
Balance, shares at Dec. 31, 2022 51,476,445        
Common stock issued in public offering, net of issuance costs [1] $ 41 208,825 208,866
Common stock issued in public offering, net of issuance costs, shares [1]   39,248,028        
Stock-based compensation 18,484 18,484
Stock-based compensation, shares   632,962        
Common stock issued upon exercises of warrants $ 1 834 $ 835
Common stock issued upon exercises of warrants, shares   557,733       557,733
Other comprehensive loss 510 $ 510
Net loss (203,693) (203,693)
Surrender and cancellation of common stock (197) $ (197)
Surrender and cancellation of common stock, shares   (27,681)       27,681
Reclassification of common stock liability to equity 35 $ 35
Reclassification of common stock liability to equity, shares   8,235        
Common stock issued in connection with extinguishment of notes payable 1,000 1,000
Common stock issued in connection with extinguishment of notes payable, shares   158,372        
Common stock issued upon cashless exercise of options and warrants
Common stock issued upon cashless exercise of options and warrants, shares   393,240        
Common stock issued in satisfaction of accrued issuable equity 2,600 2,600
Common stock issued in satisfaction of accrued issuable equity, shares   370,899        
Balance at Dec. 31, 2023 $ 93 829,563 (2,536) (537,723) 289,397
Balance, shares at Dec. 31, 2023 92,818,233        
Common stock issued in public offering, net of issuance costs [2] $ 9 26,387 26,396
Common stock issued in public offering, net of issuance costs, shares [2]   8,970,010        
Stock-based compensation 3,525 3,525
Stock-based compensation, shares   111,999        
Other comprehensive loss (3,309) (3,309)
Net loss (201,318) (201,318)
Common stock issuance, net 825 825
Common stock issuance, net, shares   70,665        
Balance at Dec. 31, 2024 $ 102 860,300 (5,845) (739,041) 115,516
Balance, shares at Dec. 31, 2024 101,970,907        
Common stock issued in public offering, net of issuance costs [3] $ 28 19,389 19,417
Common stock issued in public offering, net of issuance costs, shares [3]   27,347,996        
Stock-based compensation 2,764 2,764
Stock-based compensation, shares   868,095        
Common stock and warrants issued in satisfaction of consideration payable $ 10 11,750 11,760
Common stock and warrants issued in satisfaction of consideration payable, shares   9,696,882        
Common stock issued as purchase consideration of Zemetric $ 1 1,097 1,098
Common stock issued as purchase consideration of zemetric, shares   1,401,243        
Common stock issued in satisfaction of earn-out liabilities 206 206
Common stock issued as purchase consideration of zemetric, shares   189,892        
Common stock issued upon exercises of warrants $ 1 (1)
Common stock issued upon exercises of warrants, shares   653,118        
Other comprehensive loss (2,886) (2,886)
Net loss (83,385) (83,385)
Balance at Dec. 31, 2025 $ 142 $ 895,505 $ (8,731) $ (822,426) $ 64,490
Balance, shares at Dec. 31, 2025 142,128,133        
[1] Includes gross proceeds of $216,662, less issuance costs of $7,796.
[2] Includes gross proceeds of $27,004, less issuance costs of $608.
[3] Includes gross proceeds of $20,909, less issuance costs of $1,492